Stem cells show potential to safely slow progression of organ rejection in some lung transplant recipients, according to early Mayo Clinic research. This discovery offers ...
Surbhi Shah, M.B.B.S., M.D., is a hematologist at Mayo Clinic in Arizona., whose focus is on treating patients with non-cancerous blood disorders. In addition to ...
In a new study published in Nature Medicine, Mayo Clinic and several research collaborators from across the U.S., describe a successful new artificial intelligence, or ...
In a new study, Mayo Clinic researchers identified substantial health disparities in rural versus urban areas in diabetes-related deaths, with other disparities based on gender. Using ...
Leo Sakemura, M.D., Ph.D., a physician-scientist in Mayo Clinic's Division of Hematology, is working to advance immunotherapy efficacy in multiple myeloma by uncovering treatment resistance ...
Khushboo S. Gala, M.B.B.S. is a gastroenterology fellow in the Mayo Clinic School of Graduate Medical Education. She cares for patients and conducts clinical research ...
Mayo Clinic researchers replicated chronic dry mouth from radiation damage in preclinical models, laying the foundation for stem cell research to regenerate salivary tissue after ...
By Susan Barber Lindquist The efficiency and effectiveness of telemedicine exploded during the COVID-19 pandemic. For patients with Lou Gehrig's disease, also known as amyotrophic lateral ...
Genomic testing results evaluated by a team of Mayo Clinic researchers, coupled with the latest research techniques, provided a definitive diagnosis for 30.7% of families ...
Gustavo Cortes Puentes, M.D. (@DrivingPressure), is a pulmonary and critical care specialist at Mayo Clinic in Rochester, Minnesota. Originally from Colombia, he came to Mayo ...
Somatic mutations naturally occur in cells throughout human development and during aging. However, it has yet to be determined whether the frequency of somatic mutations ...
Mayo Clinic's Center for Regenerative Medicine has been renamed the Center for Regenerative Biotherapeutics. The name change reflects Mayo's new strategic focus: manufacturing next-generation biotherapeutics ...